The Biology of Pigmentation: What Clinicians Should Know
Advances in the biology of pigmentation have practical applications for dermatologic practice, according to Dr. Thierry Passeron, professor and chair of the dermatology department at the Université Côte d’Azur in Nice, France. Next Steps in Derm, in partnership with Pigmentary Disorders Exchange Symposium, interviewed Dr. Passeron about what clinicians should know about the biology of pigment …
Advances in the biology of pigmentation have practical applications for dermatologic practice, according to Dr. Thierry Passeron, professor and chair of the dermatology department at the Université Côte d’Azur in Nice, France. Next Steps in Derm, in partnership with Pigmentary Disorders Exchange Symposium, interviewed Dr. Passeron about what clinicians should know about the biology of pigment … Continue reading "The Biology of Pigmentation: What Clinicians Should Know"
Macular dermal hyperpigmentation is an umbrella term, explains Dr. Pearl E. Grimes, symposium chair and clinical professor of dermatology at the University of California, Los Angeles. In an interview with Next Steps in Derm, in partnership with Pigmentary Disorders Exchange Symposium, Dr. Grimes outlines the most common types of macular dermal hyperpigmentation and the factors that may be at play … 
Chemical peels are an underutilized modality that can provide significant benefits, according to Dr. Seaver L. Soon, immediate past president of the International Peeling Society and chair of the International Peeling Society-USA. Dr. Soon shared what dermatology clinicians should know about using superficial and medium depth chemical peels for pigmentary disorders in an interview with Next Steps … 
The many alternatives to hydroquinone make this an exciting time for using cosmeceuticals to treat pigmentary disorders, according to Dr. Heather Woolery-Lloyd, director of the Skin of Color Division at the University of Miami Miller School of Medicine’s Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery. In an interview with Next Steps in Derm, in partnership with Pigmentary Diso … 
Understanding the pathogenesis of vitiligo can help determine new treatment targets. Dr. John Harris, professor and chair of the dermatology department at UMass Chan Medical School, shared the latest advances in understanding what causes vitiligo in an interview with Next Steps in Derm, in partnership with Pigmentary Disorders Exchange Symposium. Watch as Dr. Harris explains the role of the immune … 